To evaluate the effect of nitroglycerine (NTG) on sensory and motor block onset and recovery time as well as the quality of tourniquet pain relief, when added to lidocaine (LID) for intravenous regional anesthesia in elective forearm and hand surgery.
Introduction
Intravenous regional anesthesia (IVRA) was described first in 1908 as anesthetic protocol for operation of the hand and forearm and has been commonly used for providing anesthesia and analgesia during the operation, because of its simple application, reliability, as well as cost-effectiveness 1 . In this context, using additives can help to prolong the duration of postoperative analgesia and reduce postoperative pain 2, 3 . Nowadays, various additives to analgesic agents have been identified to reduce tourniquet pain, improve block quality, as well as prolong post-deflation analgesia, including opioids, non-steroidal antiinflammatory drugs, corticostroids, and muscle relaxants 4 . But, because of some considerable side effects such as drug toxicity, slow onset and even inability to inducing effective postoperative pain relief, their administration has been significantly limited 5 .
Some recent studies evidenced the beneficial role of the addition of nitroglycerine (NTG) to other analgesics such as lidocaine (LID) for improving sensory and motor blockade, tourniquet pain, and also postoperative analgesia 6, 7 . But the results have been controversy because of different administered drug dosages 8 .
We therefore designed this study to evaluate the effect of NTG on sensory and motor block onset and recovery time, the quality of tourniquet pain relief, and postoperative hemodynamic stability when added to LID for IVRA in patients who undergoing elective forearm and hand surgery.
Methods
The trial was registered with and approved by the On arrival to the operating room, standard monitoring was (1) severe (lead to general anesthesia). The patients were also asked
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Acta Cirúrgica Brasileira -Vol. 28 (1) 2013 -21 about the pain quality based on the following scoring: (0) none (without any pain description); (1) mild pain (report the pain to physician but without any facial symptoms); (2) moderate (pain description with appearing facial or body manifestations; and (3) severe (patient's complain with evidenced changes as crying or frowning.
Results were reported as mean ± standard deviation (SD) for the quantitative variables and percentages for the categorical variables. The groups were compared using the t test or MannWhitney U test for the continuous variables and the chi-square test (or Fisher's exact test if required) for the categorical variables.
Trend of the changes in homodynamic parameters were assessed using the repeated measure for ANOVA test. P values of 0.05 or less were considered statistically significant. All the statistical analyses were performed using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
Results
The overall mean age of study population was 31.21 ± 14.57 years (ranged 16 to 81 years) and 75% of them were male.
The study participants who received LID and NTG and those who administered only LID were similar with respect to the average age (Table 1) , there was no significant difference between the two study groups in HR, SBP, DBP, and SpO2 before tourniquet inflation, at any time after inflation as well as after its deflation, except for measured heart rate 15 minutes before tourniquet inflation that was slightly higher in the group received both drugs (Mann-Whitney U test).
Assessing trends of the changes in hemodynamic indices across the two groups showed no significant differences between them (the repeated measure ANOVA test) (Figures 1 and 2) . There was also no significant difference in the mean of VAS score for pain measured over time between the two groups (t test) ( Table 2) .
Asadi HK et al. The mean onset time of both sensory and motor blockades was shorter in the group received both LID and NTG compared with another group (t test) ( Table 3) . Also, the mean recovery time of sensory blockade was significantly longer in the former group, while the mean recovery time of motor blockade was comparable between them.
The frequency of opioid injections were significantly lower in those who administered LID and NTG than another group, but two groups were similar in terms of the mean time of tourniquet deflation, pain severity after tourniquet deflation, onset time of pain appearance, quality of analgesia on both surgeon and patient view, mean time of the first injected dose of opioid, as well as frequency of analgesic injection within first 6 hours after tourniquet deflation (Table 4) . 
Discussion
In the present study, we could show the superiority of administrating LID combined with NTG to isolated administration of LID with respect to shortening the onset of sensory and motor block, prolongation of the recovery time of sensory blockade, and decreasing frequencies of opioid injections. However, the two regimens had similar effects on pain severity after tourniquet deflation, onset time of pain appearance, quality of analgesia on both surgeon and patient view, and the time of the injected doses of opioids. In fact, the concurrent use of LID and NTG can result more in high patients' satisfaction and prolonged analgesic effects than the used of isolated LID. Furthermore, no drug-related side effect was pointed in our study subjects. The beneficial effects of the former regimen were achieved using NTG 200 µg that might be an optimal drug dosage for this aim. Similar to our study and for the first time, Sen et al. 9 demonstrated that the NTG with the similar dose of 200 μg led to lower that postoperative VAS scores were significantly lower for the first 4 h postoperatively. In another study by Abbasivash et al. 10 and using similar dose of NTG as 200 μg, the sensory and motor block onset time were shortened, the recovery time of sensory and motor block and onset of tourniquet pain were prolonged, analgesia time after tourniquet deflation was prolonged and tourniquet pain intensity was also lowered in study group with no significant side effects. Besides, Honarmand et al. 10 revealed that the addition of 400 μg NTG to LID improved the speed of onset and the quality of anesthesia and decreased tourniquet pain and intraoperative and postoperative analgesic consumption better than the addition of the other two doses of 200 μg or 300 μg NTG, without any significant side effects. In fact, although administration of NTG 200 μg can be appropriate for obtaining optimal time for the onset of sensory and motor block and recovery time of sensory blockade, but the increase of its dosages up to 400 μg can lead to achieving higher quality of anesthesia and more decrease in tourniquet pain 11 . The beneficial effects of NTG seems to be influenced by a direct potent vasodilatory effect that promotes distribution of lidocaine to nerves that is mainly dose dependant and can be increased by elevating drug dosages [12] [13] [14] . The details of the pain relieving mechanism of NTG have been well understood. NTG exerts its analgesic effect as it is metabolized to nitric oxide (NO) in the cell 15 . NO causes an increase in the intracellular concentration of cyclic guanosine monophosphate, which produces pain modulation in the central and peripheral nervous systems 16 . NO generators also induce anti-inflammatory effects and analgesia by blocking hyperalgesia and the neurogenic component of inflammatory edema by topical application 17 . The rapid onset of sensory and motor blocks in NTG group than ketamine group could be explained by the direct strong vasodilator effect that promotes distribution of lidocaine to nerves 17 .
In our study, although use of NTG concomitantly with LID resulted in rapid onset of blockade, but its dosage seems not to be suitable for removing tourniquet-related pain or frequency of postoperative requested opioids. Tourniquet pain, which is described as a dull and aching pain sensation, is a well-known limitation of IVRA. Skin compression 18 , tourniquet size 19 , inflation pressure 20 , and adjuvants in the LA solution 21 have been implicated as factors involved in tourniquet pain. Tourniquet pain is thought to be mediated by impulse propagation via small, unmyelinated, slow-conducting C fibers 21 . In addition to spinal cord NMDA receptors, NMDA receptors have also been identified on peripheral unmyelinated sensory axons 22 . It seems that higher doses of NTG are needed to neutralize neural impulses and painrelated conducting nerve fibers. It is still need to compare between different adjuvant to discover the ideal one especially for the prolonged post-deflation analgesia. Also, because of considering small sample size, some results related to no differences in the changes of hemodynamic parameters between the intervention and control group might be explained by this subject. Thus, further similar studies with greater sample sizes for obtaining more accurate findings are strongly recommended.
Conclusion
The adjuvant drug of NTG when added to LID is effective in improving the overall quality of anesthesia, shortening onset time of both sensory and motor blockades, and stabling homodynamic parameters in hand and forearm surgery.
